23/04/2014 20:53:43 Free Membership Login

Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2012 Financial Results on May 3, 2012

Date : 04/24/2012 @ 4:00PM
Source : PR Newswire (US)
Stock : Cadence Pharmaceuticals, Inc. (MM) (CADX)
Quote : 14.0  0.0 (0.00%) @ 2:05AM
Cadence Pharmaceuticals, Inc. (MM) share price Chart

Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2012 Financial Results on May 3, 2012

Cadence Pharmaceuticals, Inc. (MM) (NASDAQ:CADX)
Historical Stock Chart

2 Years : From Apr 2012 to Apr 2014

Click Here for more Cadence Pharmaceuticals, Inc. (MM) Charts.

SAN DIEGO, April 24, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today announced that it will release its first quarter ended March 31, 2012 financial results on Thursday, May 3, 2012.

Cadence management will host a conference call and live webcast to discuss the financial results on Thursday, May 3, 2012 at 1:30 pm Pacific Time (4:30 pm Eastern Time). Interested investors may participate in the conference call by dialing (877) 303-9145 (domestic) or (760) 536-5203 (international).  To access the webcast, please visit the company's website at www.cadencepharm.com and go to the Investor Relations page.  A replay of the webcast will be available approximately two hours after the call and remain available on the company's website until the next quarterly financial results call.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting.  The current version of Cadence Pharmaceuticals' corporate overview may be viewed on the "Investors" page of www.cadencepharm.com, under "Events and Presentations." 

Contacts: 

William R. LaRue                                                                   



SVP & Chief Financial Officer                       



Cadence Pharmaceuticals, Inc.                       



858-436-1400

SOURCE Cadence Pharmaceuticals, Inc.

Copyright 2012 PR Newswire



NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us 140423 20:53